All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-LY686 | Anti-RALGAPA1 (2382C1a) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 2382C1a | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY687 | Anti-RALGAPA1 (8C170) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 8C170 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY688 | Anti-RALGAPA1 (CBLG1-3099) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-3099 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY689 | Anti-RALGAPA1 (CBLG1-3100) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBLG1-3100 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY690 | Anti-RALGAPA1 (CBLG1-2430) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2430 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2326 | Anti-RALGAPA1(2382C1a) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 2382C1a | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2327 | Anti-RALGAPA1(8C170) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 8C170 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2328 | Anti-RALGAPA1(CBLG1-3099) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-3099 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2329 | Anti-RALGAPA1(CBLG1-3100) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBLG1-3100 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2330 | Anti-RALGAPA1(CBLG1-2430) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2430 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION